An experimental inhibitor regrew cartilage in aged mice, opening up an alternative to arthritis and prosthetics.
Blocking an aging enzyme restored cartilage thickness and structure Treated joints showed lower osteoarthritis severity after injury Human cartilage cells also demonstrated regenerative activity ...
For the first time ever, an anti-aging drug is providing hope for millions who suffer from this common condition.
A single shot that appears to regrow worn knee cartilage and head off arthritis sounds like science fiction, yet early data from aging and cartilage research are edging that idea closer to reality.
Osteoarthritis, a painful condition where bone grinds against bone due to cartilage degradation, affects over 500 million people worldwide, with the knee being the most commonly afflicted joint, ...
Replacing cartilage is a stubborn problem, but new research shows a few potential paths forward. Millions of U.S. residents—perhaps up to 3 percent of the population—have an artificial hip, knee, or ...
This study led by Prof. Qiuyu Zhang (Northwestern Polytechnical University), Prof. Ki-Bum Lee (Rutgers University), and Prof. Liang Kong (School of Stomatology, The Fourth Military Medical University) ...
Researchers from Stanford University have reported that inhibiting the enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) promoted cartilage regeneration in mouse models of osteoarthritis due to ...
Knees contain two types of cartilage: articular and meniscus. Articular cartilage helps the knee move freely. Meniscus cartilage serves as a cushion or shock absorber between the bones. Sports ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Replacing cartilage is a stubborn problem, but new research shows a few potential paths forward. Millions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results